Skip to content
Advertisement

The logo for Teva appears above a trading post on the floor of the New York Stock Exchange, Monday, Oct. 21, 2019. The nation's three dominant drug distributors and a big drugmaker have reached an over $200 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday. Drugmaker Teva would contribute $20 million in cash and $20 million worth of suboxone, a drug used to treat opioid addiction. (AP Photo/Richard Drew) **FILE**
Photo by: Richard Drew
The logo for Teva appears above a trading post on the floor of the New York Stock Exchange, Monday, Oct. 21, 2019. The nation's three dominant drug distributors and a big drugmaker have reached an over $200 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday. Drugmaker Teva would contribute $20 million in cash and $20 million worth of suboxone, a drug used to treat opioid addiction. (AP Photo/Richard Drew) **FILE**

Featured Photo Galleries